Case of vancomycin-resistant Enterococcus faecium infection associated with a transjugular intrahepatic portosystemic shunt that was treated with quinupristin/dalfopristin after bacteremia persisted with alatrofloxacin therapy.
Zaman
M M
MM
Department of Medicine, Coney Island Hospital and State University of New York Health Science Center at Brooklyn, 11235, USA.
Recco
R
R
Tejwani
U
U
Scuto
T J
TJ
Ahmed
S
S
Hypolite
A
A
Jayaraman
G
G
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000188:drug therapy*; D016984:Enterococcus faecium / Q000187:drug effects*; D024841:Fluoroquinolones; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019168:Portasystemic Shunt, Transjugular Intrahepatic / Q000009:adverse effects*; D020713:Vancomycin Resistance; D014769:Virginiamycin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D014769:Virginiamycin; C062940:quinupristin-dalfopristin; C106856:alatrofloxacin